Microglial Phenotypes and Functions in Multiple Sclerosis

  1. Oleg Butovsky1,3
  1. 1Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115
  2. 2Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria
  3. 3Evergrande Center for Immunologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115
  1. Correspondence: obutovsky{at}rics.bwh.harvard.edu

Abstract

Microglia are the resident immune cells that constantly survey the central nervous system. They can adapt to their environment and respond to injury or insult by altering their morphology, phenotype, and functions. It has long been debated whether microglial activation is detrimental or beneficial in multiple sclerosis (MS). Recently, the two opposing yet connected roles of microglial activation have been described with the aid of novel microglial markers, RNA profiling, and in vivo models. In this review, microglial phenotypes and functions in the context of MS will be discussed with evidence from both human pathological studies, in vitro and in vivo models. Microglial functional diversity—phagocytosis, antigen presentation, immunomodulation, support, and repair—will also be examined in detail. In addition, this review discusses the emerging evidence for microglia-related targets as biomarkers and therapeutic targets for MS.

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge